These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3705020)

  • 21. Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
    Holm B; Godal HC
    Thromb Res; 1984 Aug; 35(3):279-90. PubMed ID: 6431629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease.
    Lipinski B; Lipinska I; Nowak A; Gurewich V
    J Lab Clin Med; 1977 Jul; 90(1):187-94. PubMed ID: 406338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Half life determination of 131 I marked fibrinogen on patients with liver cirrhosis and esophageal varices].
    Leonhardt H; Bungert HJ; Schmidt H; von Wolff C
    Med Welt; 1971 Oct; 43():1716-7. PubMed ID: 5132715
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioiodinated fibrinogen distribution in cancer patients.
    Casara D; Cartei G; Costa S
    Eur J Nucl Med; 1980; 5(1):27-9. PubMed ID: 6155267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical characteristics of a high molecular weight renin from the renal cortex of the dog.
    Potter DM; McDonald WJ; Dunn PM; Metcalfe J
    Circ Res; 1978 Dec; 43(6):832-9. PubMed ID: 30545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep venous thrombosis and multiple regression analyses of the influence from various clincial factors on the fibrinogen half-life in surgical patients, using 125I-fibrinogen.
    Forsberg K; Törngren S
    Thromb Res; 1977 Feb; 10(2):235-44. PubMed ID: 850908
    [No Abstract]   [Full Text] [Related]  

  • 27. Behaviour of commercially prepared I-125 fibrinogen in metabolic studies.
    Bradley J; Hickman JA
    J Clin Pathol; 1975 Jun; 28(6):487-93. PubMed ID: 1141450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of 125I in breast milk following administration of labelled fibrinogen.
    Bowring CS; Ormsby PL; Keeling DH
    Br J Radiol; 1980 May; 53(629):513. PubMed ID: 7388298
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinogen survival in cirrhosis: improvement by "low dose" heparin.
    Coleman M; Finlayson N; Bettigole RE; Sadula D; Cohn M; Pasmantier M
    Ann Intern Med; 1975 Jul; 83(1):79-81. PubMed ID: 1147442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of clotting by the determination of fibrinogen catabolism.
    Blaisdell FW; Graziano CJ
    Am J Surg; 1978 Mar; 135(3):436-42. PubMed ID: 626326
    [No Abstract]   [Full Text] [Related]  

  • 31. Iodine-labelled fibrinogen: a review.
    Regoeczi E
    Br J Haematol; 1971 Jun; 20(6):649-63. PubMed ID: 4932961
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of high molecular weight urokinase and low molecular weight urokinase.
    Nobuhara M; Sakamaki M; Ohnishi H; Suzuki Y
    J Biochem; 1981 Jul; 90(1):225-32. PubMed ID: 7026550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction.
    Adler G; Eichman W; Szczepanski M; Targonska I; Jasinska A
    Thromb Res; 1998 Mar; 89(5):243-8. PubMed ID: 9645918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen turnover: demonstration of multiple pathways of catabolism.
    Sherman LA
    J Lab Clin Med; 1972 May; 79(5):710-23. PubMed ID: 5018736
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibrinogen catabolism in Plasmodium knowlesi malaria.
    Sucharit P; Reid HA
    Southeast Asian J Trop Med Public Health; 1973 Jun; 4(2):168-71. PubMed ID: 4201356
    [No Abstract]   [Full Text] [Related]  

  • 36. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
    Bell WR; Shapiro SS; Martinez J; Nossel HL
    J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA; Groeneveld E; Rijken DC
    Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radio-fibrinogen catabolism studies in human renal allograft recipients.
    Wardle EN; Uldall PR; Swinney JS
    Transplantation; 1974 Dec; 18(6):508-15. PubMed ID: 4612888
    [No Abstract]   [Full Text] [Related]  

  • 40. Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis.
    Ardaillou N; Yvart J; Le Bras P; Larrieu MJ
    Thromb Haemost; 1980 Dec; 44(3):146-9. PubMed ID: 7466742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.